Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Could This Send Moderna's Stock Soaring Back to $400?
03:45pm, Thursday, 30'th Jun 2022 The Motley Fool
The healthcare stock last hit the $400 mark in September.
Is Pfizer Stock a Buy Now?
03:30pm, Thursday, 30'th Jun 2022 The Motley Fool
Its vaccine recently obtained Emergency Use Authorization for children as young as six months.
3 Things About Moderna That Smart Investors Know
02:45pm, Thursday, 30'th Jun 2022 The Motley Fool
There's more to Moderna than its COVID-19 vaccines, which investors may not appreciate fully.
Pfizer (PFE) Inks Deal With US Government for COVID Jab Supply
02:03pm, Thursday, 30'th Jun 2022 Zacks Investment Research
Pfizer (PFE) and partner BioNTech (BNTX) enter into an agreement with the government of the United States to supply 105 million doses of its mRNA-based COVID-19 vaccine.
The Chef's Warehouse and AZEK have been highlighted as Zacks Bull and Bear of the Day
11:38am, Thursday, 30'th Jun 2022 Zacks Investment Research
The Chef's Warehouse and AZEK are part of as Zacks Bull and Bear of the Day article.
Elmo gets the COVID vaccine, and says ‘there was a little pinch, but it was OK’
05:29pm, Wednesday, 29'th Jun 2022 MarketWatch
A Sesame Street PSA in partnership with the CDC and American Academy of Pediatrics says getting young kids vaccinated is 'best way' to keep everyone healthy
FDA Panel Recommends Modifying COVID Jabs to Target Omicron
12:44pm, Wednesday, 29'th Jun 2022 Zacks Investment Research
The FDA's VRBPAC committee recommends updated COVID-19 vaccine boosters that target the Omicron variant to improve vaccine effectiveness.
Novavax's 22% Post-Earnings Plunge: 5 Factors That Took Toll
11:00am, Tuesday, 10'th May 2022 Benzinga
Novavax, Inc. (NASDAQ: NVAX) shares slumped 22.27% after-hours on Monday, reacting to its quarterly financial report. What would have been a trophy quarter to flaunt, given COVID-19 revenue only just
J&J (JNJ) Updates COVID Jab Label to Include Blood Clot Risk
03:09pm, Monday, 09'th May 2022 Zacks Investment Research
J&J's (JNJ) decision to update the label of its COVID-19 vaccine came on the heels of the FDA's decision to limit the authorized use of its vaccine due to the risk of TTS.
New study finds omicron no less severe than earlier variants, and not just more transmissible
12:16pm, Monday, 09'th May 2022 MarketWatch
A new study conducted by researchers at Harvard Medical School among others has found that the omicron variant of the coronavirus that causes COVID-19 is just as severe as earlier variants, and not mo
Jim Cramer Shares His Thoughts On Chubb, Novavax And More
12:13pm, Monday, 09'th May 2022 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes the long-term prospects of Plug Power Inc (NASDAQ: PLUG). "Right now, this is a very tough day for a stock like Plug Power," he added
These 13 Nasdaq-100 stocks had the biggest swings up and down after the Fed raised rates. Should you be scared off?
11:37am, Monday, 09'th May 2022 MarketWatch
Airbnb, eBay and Moderna were among the stocks with the biggest price swings during two wild trading sessions.
Is Vertex Pharmaceuticals' Billion-Dollar Business Getting Even Bigger?
10:00am, Monday, 09'th May 2022 The Motley Fool
The company may extend its leadership in cystic fibrosis treatment.
3 Growth Stocks That Are Screaming Buys in May
12:30pm, Sunday, 08'th May 2022 The Motley Fool
Growth stocks have gotten cheap in the market sell-off.
4 Bold Words From Moderna's CEO That Could Be Worth Billions
10:00am, Sunday, 08'th May 2022 The Motley Fool
They have to do with the future.
